Solid Biosciences Granted FDA ODD For SGT-003
(RTTNews) - Solid Biosciences Inc. (SLDB) on Tuesday, announced that the FDA has granted Orphan Drug Designation (ODD) for its next-generation Duc...
Source: businessinsider.com
Page 5 - Solid Biosciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Solid Biosciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Solid Biosciences Today - Breaking & Trending Today
AAV Vectors in Gene Therapy Market is Predicted to Observe Skyrocketed Growth During the Study Period (2019-2032)
/PRNewswire/ -- DelveInsight's AAV Vectors in Gene Therapy Market Insights report includes a comprehensive understanding of current treatment practices,...
Source: prnewswire.com
Insider Selling: Solid Biosciences Inc. (NASDAQ:SLDB) CFO Sells 3,935 Shares of Stock
Solid Biosciences Inc. (NASDAQ:SLDB – Get Free Report) CFO Kevin Tan sold 3,935 shares of the company’s stock in a transaction on Tuesday, January 9th. The stock was sold at an average price of $8.20, for a total value of $32,267.00. Following the sale, the chief financial officer now directly owns 9,308 shares in the […]
Source: modernreaders.com
Solid Biosciences Inc. announced that it expects to receive $108.858551 million in funding from a group of investors
Solid Biosciences Inc. entered into a securities purchase agreement with certain institutional accredited investors to issue common stock and Pre-Funded warrants for a aggregate proceeds of...
Source: marketscreener.com
In-Depth Market Analysis of Rare Genetic Disorders: Familial Chylomicronemia Syndrome (FCS), Netherton Syndrome, and Acromegaly
/PRNewswire/ -- Significant breakthroughs in the rapid and cost-effective analysis of the human genome have brought clarity to the path of discovering the...
Source: prnewswire.com